Chemotherapie - Die wöchentliche Paclitaxel-Therapie in der adjuvanten Brustkrebstherapie

Literatur

• 01 Sparano JA . Wang M . Martino S . et al . Weekly Paclitaxel in the Adjuvant Treatment of Breast Cancer.  N Engl J Med. 2008;  358 1663-1671
• 02 Rodríguez-Lescure A. SABCS 2005, Abstract # 39. 
• 03 Seidman AD . Berry D . Cirrincione C . et al . Randomized Phase III Trial of Weekly Compared With Every-3-Weeks Paclitaxel for Metastatic Breast Cancer, With Trastuzumab for all HER-2 Overexpressors and Random Assignment to Trastuzumab or Not in HER-2 Nonoverexpressors: Final Results of Cancer and Leukemia Group B Protocol 9840.  J Clin Oncol. 2008;  26 1585-1587
• 04 Jones SE . Erban J . Overmoyer B . et al . Randomized Phase III Study of Docetaxel Compared With Paclitaxel in Metastatic Breast Cancer.  J Clin Oncol. 2005;  23 5542-5551